Treatment of Chemotherapy-induced Nausea and Vomiting
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Delayed nausea is a common problem after high dose chemotherapy for bone marrow
transplantation. This study wants to compare standard prophylactic anti-emetic therapy with
the same treatment plus the drug aprepitant (Emend). The hypothesis is that addition of Emend
will reduce nausea and vomiting.